{"@id":"https://bioecon.ru/technology/phenotype-first-ai-drug-discovery/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://cn.bioecon.ru/technology/phenotype-first-ai-drug-discovery/","json":"https://cn.bioecon.ru/api/v1/technology/phenotype-first-ai-drug-discovery/index.json"},"id":"phenotype-first-ai-drug-discovery","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/schr-dinger/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/rev-genomics/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/atomwise/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/micropep-technologies/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/turion-labs/"]},"maturity":7,"name":"“表型优先”人工智能驱动活体微流控药物发现与先导化合物生成闭环平台","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"生成式AI结构深度学习多目标分子虚拟设计"},{"n":2,"title":"自动化芯片线虫人类重大疾病模型活体药效快筛"},{"n":3,"title":"计算机视觉自学习表型挽救与神经运动功能恢复打分"},{"n":4,"title":"光亲和交联结合化学生物蛋白质组学作用靶标反向拆解"}],"summary":"打破传统“先靶点后化合物”教条的全新药物发现闭环体系，利用生成式AI深度学习架构从头设计或虚拟筛选类药分子库，直接注入秀丽隐杆线虫人类神经退行性疾病或代谢病微流控活体动物模型中进行高通量运动与寿命挽救表型验证，在活体系统确立显著疗效后再反向运用化学蛋白质组学解析其作用机制与精确靶标。","url":"/technology/phenotype-first-ai-drug-discovery/","verified":"2026-11-22"}